The 52-Week-High List: 31 Small Cap Names On Monday
A selective list of new highs shows strength concentrated in a few key industries.
On Monday, 31 Small Cap stocks in the Russell 3000 reached a 52-week high. The largest company on the list is Immunovant (IMVT), with a market value of about $8.9 billion. But the real story is the list’s narrowness: a full 6 names come from the Biotechnology industry, while another 6 are split between two industries in the Energy sector. Is this a market rewarding only very specific stories?
Below is the complete list of small-cap names at their one-year peak.
The Biggest Names On The List
- The 52-Week-High List: 13 S&P 500 Names On Tuesday
- 25 Small Cap Stocks Just Made New 52-Week Highs
- S&P 500 Movers | Winners: TRGP, PODD, ULTA | Losers: COHR, LITE, STX
- Where The Selling Ran Deepest: 5 S&P 500 Stocks At 52-Week Lows
- Mid Cap Stocks At 52-Week Highs: Tuesday’s Full List
- 23 Stocks Hit 52-Week Lows On Tuesday
The table below shows the 10 largest of the 31 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| IMVT | $8.89 Bil | 4.5% | 9.6% | 8.6% | 187.6% |
| CRNX | $8.82 Bil | 0.1% | 0.7% | 1.1% | 185.4% |
| PBF | $8.8 Bil | 4.5% | 13.7% | 20.1% | 239.2% |
| AVT | $8.09 Bil | 3.1% | 1.3% | 15.2% | 86.5% |
| NOV | $7.8 Bil | 2.2% | 4.3% | 10.7% | 79.4% |
| VCTR | $7.56 Bil | 0.5% | 6.6% | 20.6% | 71.5% |
| SM | $7.06 Bil | 5.1% | 11.7% | 13.3% | 37.5% |
| NOVT | $6.82 Bil | 1.3% | 3.0% | 13.5% | 42.8% |
| VSEC | $6.7 Bil | 0.7% | 10.1% | 22.0% | 48.9% |
| CGON | $6.52 Bil | 2.8% | 0.7% | 7.3% | 197.0% |
Which names show a business keeping up with the price?
A new high invites a look at the fundamentals. PBF Energy (PBF), which gained 20.1% over the last month, trades at 6.6 times trailing earnings. Its revenue grew 13.5% over the last twelve months and its operating margin is 2.6%. Contrast that with NOV (NOV), which trades at 81.6 times trailing earnings while its revenue declined 1.7% over the same period.
How should a disciplined investor use this list?
Strength often persists, and a stock at its high is there for a reason. But a price is not a verdict. A 52-week high is the beginning of the work, not the end. The disciplined move is to check whether the business performance, from revenue growth to margins, truly earns the new level the market has granted it.
Before chasing any name on this list, ask what the company itself expects next. Our Guidance Momentum screen surfaces the stocks whose managements just raised their own outlooks, which is the momentum that tends to have staying power.
New Highs Fade. Discipline Compounds
Some of the names on this list will keep setting highs for years, and some are at the top of their run right now. Sorting one from the other, name by name, every day, is the work most investors never keep up with.
That sorting is what the Trefis High Quality (HQ) Portfolio does systematically: about 30 quality businesses screened for the fundamentals that sustain a run, held with rules instead of excitement. It has a track record of outpacing a benchmark that combines the three major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Use the high list for ideas; use the portfolio for the compounding.